Tivdak 40 MG vials
Ended Awarded
- Contract number
- SPE2DB25FSZ86
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,374
Award facts
- Contract value 100% obligated
- $19,374.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,374.16 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of TIVDAK 40 mg vials. This firm fixed-price delivery order, with an ultimate completion date of October 7, 2025, represents a specific pharmaceutical procurement issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete directly in the federal marketplace based on its qualifications and pricing. Performance will be fulfilled from the awardee's location in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler registered in SAM.gov since 2001, serves as a critical supplier within the federal pharmaceutical supply chain. The company holds a significant single-award IDC with DLA valued at $499,999,999 through November 2026 under the SPE2DB program, which enables the issuance of delivery orders for pharmaceutical products supporting military health facilities worldwide. This delivery order for TIVDAK—a pharmaceutical product distributed through the company's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables—exemplifies DMS Pharmaceutical Group's ongoing role in providing essential medications to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FSZ86?
SPE2DB25FSZ86 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FSZ86 worth?
The government has obligated $19,374 on SPE2DB25FSZ86.
Is contract SPE2DB25FSZ86 an order under another contract?
Yes. SPE2DB25FSZ86 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ86 competed?
The extent of competition for SPE2DB25FSZ86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award